Antibiotic susceptibility of invasive Haemophilus influenzae strains in Canada

Michelle L Sill1, Raymond S W Tsang

  • 1Vaccine Preventable Bacterial Diseases, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.

Insights

Antibiotic resistance in invasive Haemophilus influenzae is increasing in Canada. Researchers observed a rise in beta-lactamase-negative ampicillin-intermediate strains between 1990 and 2006.

Area of Science:

  • Medical Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Haemophilus influenzae is a significant cause of invasive bacterial infections.
  • Antibiotic resistance in H. influenzae poses a growing public health concern.
  • Monitoring antimicrobial susceptibility patterns is crucial for effective treatment.

Purpose of the Study:

  • To analyze antibiotic susceptibility trends of invasive Haemophilus influenzae isolates in Canada.
  • To identify changes in resistance patterns, particularly to ampicillin, over a 17-year period.

Main Methods:

  • Retrospective analysis of Canadian invasive H. influenzae isolates collected from 1990 to 2006.
  • Antimicrobial susceptibility testing, including assessment of beta-lactamase production.
  • Categorization of resistance and intermediate susceptibility to ampicillin.

Main Results:

  • Out of 42 examined strains, 17.8% showed ampicillin resistance due to beta-lactamase production.
  • 5.5% of strains were beta-lactamase negative and ampicillin intermediate.
  • 2.5% of strains exhibited intermediate susceptibility to a 2-microg ampicillin disk.

Conclusions:

  • A notable increase in beta-lactamase-negative ampicillin-intermediate H. influenzae strains was observed.
  • These findings highlight evolving resistance mechanisms and the need for ongoing surveillance.
  • Updated treatment guidelines may be necessary to address changing susceptibility profiles.

Related Concept Videos

Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Antibiotic Selection00:57

Antibiotic Selection

Overview
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...